What is Peutz-Jeghers syndrome

Peutz-Jeghers syndrome is a rare, inherited genetic condition characterized by the development of benign polyps in the gastrointestinal tract and distinct dark-colored skin pigmentation. Individuals living with Peutz-Jeghers syndrome face an increased lifetime risk of developing various types of cancer, necessitating lifelong clinical surveillance and specialized medical management.

What are the primary characteristics of Peutz-Jeghers syndrome?

The hallmark features of Peutz-Jeghers syndrome involve both physical manifestations and internal health risks. Most individuals develop hamartomatous polyps—a specific type of benign growth—primarily in the small intestine, though they can also occur in the stomach and colon. These polyps can cause complications such as abdominal pain, intestinal obstruction, or chronic bleeding. Additionally, many patients exhibit mucocutaneous pigmentation, appearing as small, dark blue, brown, or black spots on the lips, inside the mouth, around the nose, or on the fingers and toes. These spots are often present in childhood and may fade during adulthood, though they serve as a critical diagnostic clue for Peutz-Jeghers syndrome.

What causes Peutz-Jeghers syndrome?

Peutz-Jeghers syndrome is primarily caused by mutations in the STK11 (also known as LKB1) gene. This gene is responsible for producing a protein that acts as a tumor suppressor, helping to regulate cell growth and division. When this gene is mutated, the body’s ability to control the growth of polyps is compromised. The condition follows an autosomal dominant inheritance pattern, meaning an affected individual has a 50% chance of passing the gene mutation to each of their children. However, approximately 25% of cases arise from a "de novo" or new mutation, meaning the individual is the first in their family to be affected.

How common is Peutz-Jeghers syndrome?

Peutz-Jeghers syndrome is considered a rare disorder, with an estimated prevalence ranging from 1 in 50,000 to 1 in 200,000 individuals worldwide. Because the condition is rare and symptoms can vary widely—even among members of the same family—some cases may go undiagnosed for years. Within the DiseaseMaps.org community, 167 people with Peutz-Jeghers syndrome have joined to share their experiences, highlighting the importance of connecting with others who understand the unique challenges of this diagnosis.

What are the key health risks associated with the condition?

The most significant concern for those with Peutz-Jeghers syndrome is the elevated risk of malignancy. While the polyps themselves are benign, they can lead to secondary health issues and may undergo malignant transformation. The lifetime cancer risk for patients is significantly higher than that of the general population, with common sites including:

• Gastrointestinal tract (stomach, small intestine, colon, and rectum)


• Pancreas


• Breast


• Ovaries and cervix (in females)


• Testes (specifically Sertoli cell tumors in males)

How is Peutz-Jeghers syndrome differentiated from other conditions?

It is important to distinguish Peutz-Jeghers syndrome from other polyposis syndromes like Juvenile Polyposis Syndrome or Cowden syndrome. The combination of hamartomatous polyps and characteristic skin pigmentation is highly specific to this condition. Unlike other syndromes that primarily affect the colon, Peutz-Jeghers syndrome is unique in its tendency to affect the small intestine, which often requires specific diagnostic imaging like capsule endoscopy or double-balloon enteroscopy to monitor.

Next steps

• Consult a gastroenterologist or a clinical geneticist to discuss surveillance protocols.


• Schedule regular screenings for gastrointestinal, breast, and reproductive cancers as recommended by your specialist.


• Connect with the 167 members of the DiseaseMaps.org community to share support and management strategies.


• Seek genetic counseling to understand the implications for family planning and testing for relatives.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases (GARD) Information Center: Peutz-Jeghers syndrome overview.


• Orphanet: Rare disease database entry for Peutz-Jeghers syndrome (ORPHA713).


• Online Mendelian Inheritance in Man (OMIM): STK11 gene and Peutz-Jeghers syndrome (Entry #175200).


• National Cancer Institute (NCI): PDQ Cancer Information Summary for Peutz-Jeghers syndrome.